Fragasso Financial Advisors’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Fragasso Financial Advisors’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$444K	Buy	6,699 +6	+0.1%	+$352	0.02%	231
2026 Q1	$364K	Buy	6,693 +7	+0.1%	+$390	0.02%	237
2025 Q4	$374K	Buy	6,686 +13	+0.2%	+$674	0.02%	224
2025 Q3	$327K	Buy	6,673 +15	+0.2%	+$671	0.02%	228
2025 Q2	$270K	Buy	6,658 +16	+0.2%	+$643	0.02%	237
2025 Q1	$291K	Buy	6,642 +23	+0.3%	+$1.01K	0.02%	220
2024 Q4	$285K	Buy	6,619 +24	+0.4%	+$1.09K	0.02%	215
2024 Q3	$293K	Sell	6,595 -409	-6%	-$17.5K	0.02%	211
2024 Q2	$279K	Sell	7,004 -4	-0.1%	-$162	0.02%	217
2024 Q1	$302K	Buy	7,008 +6	+0.1%	+$259	0.03%	205
2023 Q4	$291K	Sell	7,002 -1,073	-13%	-$40.7K	0.03%	208
2023 Q3	$321K	Hold	8,075	–	–	0.03%	183
2023 Q2	$331K	Buy	8,075 +159	+2%	+$6.57K	0.04%	185
2023 Q1	$325K	Buy	7,916 +1,416	+22%	+$59.5K	0.04%	170
2022 Q4	$266K	Buy	+6,500	New	+$271K	0.03%	178

Other funds holding XPH

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

KWM

Kingsview Wealth Management Grants Pass, Oregon $8.25B AUM 24.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Evelyn Partners London $46.9B AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Fragasso Financial Advisors's XPH Position: Q2 2026 in Review

Fragasso Financial Advisors increased its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 0.09% in Q2 2026, buying an estimated $352 and bringing the position to 6,699 shares worth $444K. The position accounts for 0.02% of the portfolio, ranked #231.

Fragasso Financial Advisors first reported a position in XPH in Q4 2022 and has held it in 15 quarters since. 93 funds tracked by Wall St. Rank hold XPH as of Q2 2026.

Fragasso Financial Advisors held 6,699 shares of State Street SPDR S&P Pharmaceuticals ETF worth $444K as of Q2 2026.
Fragasso Financial Advisors bought 6 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2026, an estimated $352.
State Street SPDR S&P Pharmaceuticals ETF made up 0.02% of Fragasso Financial Advisors's portfolio in Q2 2026, its #231 holding.
Fragasso Financial Advisors first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2022 and has held it in 15 quarters since.
93 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.

Based on Fragasso Financial Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.